Monday, January 28, 2013

Off-Label Promotion Is Free Speech in 2nd Second


Jesse C. Vivian, RPh, JD, Professor, Department of Pharmacy Practice, College of Pharmacy and Health Sciences Wayne State University, Detroit, Michigan (1/23/2013) at US Pharm. 2012;38(1):40-42 provides an interesting discussion of  U.S. v Caronia, decided on December 3, 2012, in which a federal Court of Appeals panel in a 2-1 decision ruled that the promotion of prescription drugs by manufacturer’s agents for off-label purposes is protected “free speech” under the First Amendment to the U.S. Constitution, and thus the FDA’s prohibition against such practices was ruled unconstitutional. 

To read this article click here

1 comment:

buy avanafil 200 mg online said...

Thank you for providing such valuable information. all have had so much learning from this post.